A new CAR-T therapy shows efficacy in preclinical models of hard-to-treat leukemias
Researchers from Clínic-IDIBAPS, within the Clínic Barcelona Comprehensive Cancer Center, and the spin-off Gyala Therapeutics have coordinated a stud1
Researchers from Clínic-IDIBAPS, within the Clínic Barcelona Comprehensive Cancer Center, and the spin-off Gyala Therapeutics have coordinated a stud1
Researchers from Clínic-IDIBAPS, within the framework of the Clínic Barcelona Comprehensive Cancer Center, have led a study analyzing how genetic mut1
The digital project MigraAgile, promoted by the Hospital Clínic Barcelona in collaboration with the Primary Care Centres of the Barcelona Esquerra In1
An international team led by the Clínic-IDIBAPS and the Institute of Cancer Research in London has developed an innovative new method based on DNA me1
A study by the Clínic – IDIBAPS, carried out with mice, explores the therapeutic potential of this natural compound.
A study led by the Hip Section of the Orthopaedic Surgery and Traumatology Service and the Surgical Area of the Hospital Clínic shows that it is poss1
The company has secured 1.2 million euros from the Ministry of Science, Innovation and Universities’ call for public-private collaboration projects t1
Ferran Nadeu, a researcher in the IDIBAPS research group Molecular pathology of lymphoid neoplasms located at Esther Koplowitz Centre1
Twenty-five years ago, Catalonia pioneered the launch of the first colorectal cancer screening programme in Spain. The first studies had appeared sho1
A study led by the Clínic-IDIBAPS reveals that the microbiota can predict and enhance patient response to one of the most innovative immunotherapies1